Mylan Pharmaceuticals Inc. et al. v. Boehringer Ingelheim Pharmaceuticals Inc. et al. > Summary
Court Case Number IPR2016-01564
Filing Date Aug 10, 2016
Institution Decision Date Jan 31, 2017
Decision Date Jul 18, 2017
Court Patent Trial and Appeal Board
Status Terminated
Administrative JudgesToni R. Scheiner, Brian P. Murphy, Zhenyu Yang
Judge Writing the Final DecisionZhenyu Yang
Claims Challenged in the Petition: 1, 2, 3, 4
Claims Instituted: 1, 2, 3, 4
Claims Invalidated: 1, 2, 3, 4
Petitioner
Patent Owner
Petitioner Attorneys
4Viatris Inc.
Attorney Name: Charles Naggar
Alston & Bird
Viatris Inc.
Attorney Name: Christopher L. McArdle
Alston & Bird
Viatris Inc.
Attorney Name: Ellen Yueh-Ning Cheong
Alston & Bird
Viatris Inc.
Attorney Name: Thomas M. Parker
Alston & Bird
Patent Owner Attorneys
5Boehringer Ingelheim International GmbH
Attorney Name: Eugene Goryunov
Kirkland & Ellis
Boehringer Ingelheim International GmbH
Attorney Name: Leora Ben-Ami
Kirkland & Ellis
Boehringer Ingelheim International GmbH
Attorney Name: Michael Peter Morris
Boehringer Ingelheim International GmbH
Attorney Name: Jeanna M. Wacker
Kirkland & Ellis
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 08846695 | Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy comprising a DPP-IV inhibitor | Sep 30, 2014 |
